News

EconoTimes8d
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Shares of Neuren Pharmaceuticals Ltd (ASX:NEU) jumped over 10% on Thursday after the company announced a key development in ...
HotCopper on MSN8d
Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment
Neuren Pharma (ASX:NEU) has seen its shares jump over +11% as the company wins a patent to treat Pitt Hopkins Syndrome (PTHS) ...
Morningstar2mon
Unravel Biosciences Announces Submission of RVL-001 Clinical Study Applications for Rett Syndrome and Pitt Hopkins Syndrome to Colombian Health Regulatory Authority - Morningstar
In addition to Unravel's RVL-001 program for RTT and PTHS, the company has also initiated development work on RVL-002, a first-in-class novel molecule for Rett syndrome. "The Rett and Pitt Hopkins ...